VIEWS and NEWS <br> A celery gene may protect roses from disease • 15th European Congress on Biotechnology • Environmental Microbiology
and Biotechnology Conference 2012 • FDA approved first cell therapy against wrinkles • Individualization
of cancer treatment using personalized tumorgrafts • Mission Therapeutics Ltd, a new British spin-out company, raised
£6 million • Science Multimedia Center

Joanna Przybył

doi:10.5114/bta.2011.46537

eISSN: 2353-9461
ISSN: 0860-7796

BioTechnologia

Current issue Archive About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Newsletter

Enter your email:

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

3/2011
vol. 92

Send email

Copy url:

Joanna Przybył

BioTechnologia vol. 92(3) C pp. 221-223 C 2011

DOI: https://doi.org/10.5114/bta.2011.46537

Online publish date: 2014/10/28

Article file

- 02.pdf [0.08 MB]

Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Przybył J. VIEWS and NEWS  A celery gene may protect roses from disease • 15th European Congress on Biotechnology • Environmental Microbiology
and Biotechnology Conference 2012 • FDA approved first cell therapy against wrinkles • Individualization
of cancer treatment using personalized tumorgrafts • Mission Therapeutics Ltd, a new British spin-out company, raised
£6 million • Science Multimedia Center. BioTechnologia. 2011;92(3):221-223. doi:10.5114/bta.2011.46537.

APA

Przybył, J. (2011). VIEWS and NEWS  A celery gene may protect roses from disease • 15th European Congress on Biotechnology • Environmental Microbiology
and Biotechnology Conference 2012 • FDA approved first cell therapy against wrinkles • Individualization
of cancer treatment using personalized tumorgrafts • Mission Therapeutics Ltd, a new British spin-out company, raised
£6 million • Science Multimedia Center. BioTechnologia, 92(3), 221-223. https://doi.org/10.5114/bta.2011.46537

Chicago

Przybył, Joanna. 2011. "VIEWS and NEWS  A celery gene may protect roses from disease • 15th European Congress on Biotechnology • Environmental Microbiology
and Biotechnology Conference 2012 • FDA approved first cell therapy against wrinkles • Individualization
of cancer treatment using personalized tumorgrafts • Mission Therapeutics Ltd, a new British spin-out company, raised
£6 million • Science Multimedia Center". BioTechnologia 92 (3): 221-223. doi:10.5114/bta.2011.46537.

Harvard

Przybył, J. (2011). VIEWS and NEWS  A celery gene may protect roses from disease • 15th European Congress on Biotechnology • Environmental Microbiology
and Biotechnology Conference 2012 • FDA approved first cell therapy against wrinkles • Individualization
of cancer treatment using personalized tumorgrafts • Mission Therapeutics Ltd, a new British spin-out company, raised
£6 million • Science Multimedia Center. BioTechnologia, 92(3), pp.221-223. https://doi.org/10.5114/bta.2011.46537

MLA

Przybył, Joanna. "VIEWS and NEWS  A celery gene may protect roses from disease • 15th European Congress on Biotechnology • Environmental Microbiology
and Biotechnology Conference 2012 • FDA approved first cell therapy against wrinkles • Individualization
of cancer treatment using personalized tumorgrafts • Mission Therapeutics Ltd, a new British spin-out company, raised
£6 million • Science Multimedia Center." BioTechnologia, vol. 92, no. 3, 2011, pp. 221-223. doi:10.5114/bta.2011.46537.

Vancouver

Przybył J. VIEWS and NEWS  A celery gene may protect roses from disease • 15th European Congress on Biotechnology • Environmental Microbiology
and Biotechnology Conference 2012 • FDA approved first cell therapy against wrinkles • Individualization
of cancer treatment using personalized tumorgrafts • Mission Therapeutics Ltd, a new British spin-out company, raised
£6 million • Science Multimedia Center. BioTechnologia. 2011;92(3):221-223. doi:10.5114/bta.2011.46537.

PlumX metrics:

Copyright: © 2014 Institute of Bioorganic Chemistry, Polish Academy of Sciences This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/3.0/legalcode),.allowing third parties to download and share its works but not commercially purposes or to create derivative works.